-
Tamer A. Addissouky
1-3*
-
Ibrahim El Tantawy El Sayed
2
-
Majeed M. A. Ali
1
-
Yuliang Wang
4
-
Ahmed A. Khalil
1 Al-Hadi University College, Baghdad, Iraq.
2 Department of Biochemistry, Science Faculty, Menoufia University, Menoufia, Egypt.
3 MLS ministry of health, Alexandria, Egypt. - MLS ASCP, USA.
4 Joint International Research Laboratory of Metabolic and Developmental Sciences, Key Laboratory of Urban Agriculture (South) Ministry of Agriculture, Plant Biotechnology Research Center, Fudan-SJTU-Nottingham Plant Biotechnology R&D Center, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China.
5 Department of Pathology, BayState Medical Center, Springfield, Massachusetts, UNITED STATES.
*Corresponding Author: Tamer A. Addissouky, Al-HADI University College, Baghdad. Iraq. - Department of Biochemistry, Science Faculty, Menoufia University, Egypt. - MLS ministry of health, Alexandria, Egypt. - MLS, ASCP, USA.
Citation: Tamer A. Addissouky., Ibrahim El Tantawy El Sayed., Majeed M. A. Ali., Yuliang Wang., and Ahmed A. Khalil. (2024), Advances in Endometrial Ablation Techniques for Heavy Menstrual Bleeding, J. Women Health Care and Issues. 7(1); DOI:10.31579/2642-9756/183
Copyright: © 2024, Tamer A. Addissouky. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 05 January 2024 | Accepted: 19 January 2024 | Published: 25 January 2024
Keywords: endometrial ablation; heavy menstrual bleeding; pharmaceutical options; endometrial resection
Abstract
Background: Endometrial ablation is an established uterus-sparing treatment for heavy menstrual bleeding (HMB), but average amenorrhea rates remain around 50%. Ablation limitations and side effects have spurred interest in less invasive alternatives.
Purpose: This review comprehensively surveys emerging endometrial ablation techniques, regenerative and pharmaceutical options, and future directions in HMB management. It provides an updated synthesis of the latest promise and pitfalls in both established and novel therapeutic approaches.
Main body: Global ablation methods have reduced operative risks versus first generation hysteroscopic options, but treatment failures still occur. Innovations like magnetic resonance-guided focused ultrasound ablation, endometrial resection, and temporary hormonal suppression aim to further expand choices, improve outcomes, and avoid permanent ablation. However, comparative effectiveness studies are lacking and optimal patient selection unclear. This review highlights promising areas of research, while delineating limitations and knowledge gaps needing further study.
Conclusion: Continued innovation and investigation of less invasive options may personalize therapy and reduce ablation complications and retreatment rates. But robust evidence on long-term fertility, regeneration, quality of life, and cost-effectiveness is still needed guide best practices in this evolving field.
1.Introduction
Heavy menstrual bleeding (HMB), defined as excessive menstrual blood loss of over 80mL per cycle, is a common gynecological disorder estimated to affect up to 30% of women worldwide. The excessive blood loss and duration of menstruation associated with HMB can have a significant detrimental impact on a woman's physical, social, emotional and material quality of life. Anemia resulting from chronic iron deficiency is a common complication. As women age, the prevalence of HMB tends to increase due to conditions like adenomyosis, fibroids and coagulation disorders [1]. When medical management of HMB fails, endometrial ablation has emerged as an
effective alternative to hysterectomy. Endometrial ablation is a procedure that destroys the lining of the uterus (endometrium) in order to reduce or stop excessive menstrual bleeding. First generation ablation techniques utilized hysteroscopically-guided destruction of the endometrium by heated fluid, laser or electrosurgery. Global ablation methods were later introduced, which destroy the entire endometrium at once using thermal balloon, radiofrequency electrical energy, cryotherapy or microwave energy without visual guidance [2].
While clinical trials have shown endometrial ablation provides significant improvement in HMB and quality of life in most women, limitations exist. Average amenorrhea (cessation of periods) rates are only around 50% and treatment failure or unsatisfactory improvement in bleeding occurs in 15-30% of women. Post-ablation pain, infection, uterine perforation, asherman's syndrome and other complications can also occur. For these reasons, research is ongoing to evaluate new technologies and refine ablation techniques [3]. While endometrial ablation fills an important niche in heavy menstrual bleeding treatment, limitations like suboptimal amenorrhea rates, pain, and treatment failure affecting up to 30% of women underscore the need for continued innovation. This review provides an updated synthesis of emerging ablation techniques, regenerative approaches, and pharmaceutical alternatives. It delineates latest developments, knowledge gaps, and future directions in this evolving field [4]. While endometrial ablation is an established treatment for heavy menstrual bleeding, average amenorrhea rates remain only around 50% and complications prompt re-treatment in 15-30% of women. This underscores the need to survey emerging technologies like focused ultrasound, novel resection devices, and temporary pharmaceutical options that may expand choices, limit side effects, and improve outcomes. By comprehensively evaluating the latest evidence on both conventional and innovative approaches, this review provides updated recommendations to guide optimal integration of traditional techniques with disruptive innovations in this rapidly evolving ablation field.
II. Current endometrial ablation techniques
First generation endometrial ablation techniques utilized direct visualization of the uterine cavity with a hysteroscope to guide destruction of the endometrium [5]. Heated fluid, laser energy or electrosurgery with a rollerball could be directed to the lining. These hysteroscopic methods required additional training, surgical skill and longer operating room time [6]. Global endometrial ablation was later introduced as a second generation approach, allowing the entire endometrium to be treated at once without visually guiding the ablation. Common global ablation modalities include heated liquid-filled balloons, radiofrequency electrical energy, cryoablation probes and microwave devices inserted transcervically into the uterus [7].
Each ablation modality has unique benefits and risks. Heated fluid techniques like the thermal balloon can treat variable uterine shapes and are less dependent on operator skill [8]. Radiofrequency ablation is fast, simple and does not require general anesthesia in the outpatient setting. Cryoablation and microwave energy have the advantages of myocardial ablation devices which selectively destroy the endometrium while sparing deeper myometrium [9]. In clinical studies, global endometrial ablation has equaled or exceeded the amenorrhea rates of hysteroscopic ablation, ranging from 45-75
Abbreviations:
HMB - Heavy menstrual bleeding
MRgFUS - Magnetic resonance-guided focused ultrasound ablation
OR - Operating room
GnRH - Gonadotropin-releasing hormone
IUD - Intrauterine device
FDA - Food and Drug Administration
Declarations:
Ethics approval and consent to participate: Not Applicable
Consent for publication: Not Applicable
Availability of data and materials: all data are available and sharing is available as well as publication.
Competing interests: The authors hereby that they have no competing interests.
Funding:
Corresponding author supplied all study materials. There was no further funding for this study.
Authors' contributions:
The authors completed the study protocol and were the primary organizers of data collection and the manuscript's draft and revision process. Tamer A. Addissouky wrote the article and ensured its accuracy. All authors contributed to the discussion, assisted in designing the study and protocol and engaged in critical discussions of the draft manuscript. Lastly, the authors reviewed and confirmed the final version of the manuscript.
Acknowledgements:
The authors thank all the researchers, editors, reviewers, and the supported universities that have done great efforts on their studies. Moreover, we are grateful to the editors, reviewers, and reader of this journal.
References
- Ibrahim PM, Samwel EL. (2023). Prevalence of Heavy Menstrual Bleeding and Its Associated Factors Among Women Attending Kilimanjaro Christian Medical Centre In Northern Eastern, Tanzania: A Cross-Sectional Study. East Afr Health Res J.7(1):1-6.
View at Publisher |
View at Google Scholar
- Vitale SG, Della Corte L, Ciebiera M, Carugno J, Riemma G, Lasmar RB, Lasmar BP, Kahramanoglu I, Urman B, Mikuš M, De Angelis C, Török P, Angioni S. Hysteroscopic Endometrial Ablation: From Indications to Instrumentation and Techniques-A Call to Action. Diagnostics (Basel). 2023 Jan 17;13(3):339.
View at Publisher |
View at Google Scholar
- Reinders IMA, van de Kar MRD, Geomini PMAJ, Leemans JC, Maas JWM, Bongers MY. Short-term recovery after NovaSure® endometrial ablation: a prospective cohort study. Facts Views Vis Obgyn. 2022 Dec;14(4):299-307.
View at Publisher |
View at Google Scholar
- Kakinuma T, Kaneko A, Kakinuma K, Matsuda Y, Yanagida K, Takeshima N, Ohwada M. Effectiveness of treating menorrhagia using microwave endometrial ablation at a frequency of 2.45 GHz. World J Clin Cases 2023; 11(24): 5653-5659 DOI: https://dx.doi.org/10.12998/wjcc.v11.i24.5653
View at Publisher |
View at Google Scholar
- Smith, P.P., Clark, T.J. (2023). Operative Hysteroscopy. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-031-14881-1_53
View at Publisher |
View at Google Scholar
- MacGregor, Becky, Malcolm G. Munro, and Mary A. Lumsden.
View at Publisher |
View at Google Scholar
- Heylen, Anna, Jasper Verguts, Lieselore Vandermeulen, and Thierry Van den Bosch.
View at Publisher |
View at Google Scholar
- Hussain S, Sohrabi C, Providencia R, Ahsan S, Papageorgiou N. Catheter Ablation for the Management of Atrial Fibrillation: An Update of the Literature. Life (Basel). 2023 Aug 21;13(8):1784. doi: 10.3390/life13081784. PMID: 37629641; PMCID: PMC10455869.
View at Publisher |
View at Google Scholar
- Koshiro Kanaoka, Taku Nishida, Yoshitaka Iwanaga, Michikazu Nakai, Reina Tonegawa-Kuji, Yuichi Nishioka, Tomoya Myojin, Katsuki Okada, Tatsuya Noda, Kengo Kusano, Yoshihiro Miyamoto, Yoshihiko Saito, Tomoaki Imamura, Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks, European Heart Journal, 2023;, ehad798, https://doi.org/10.1093/eurheartj/ehad798
View at Publisher |
View at Google Scholar
- Minami, Yasunori, Tomoko Aoki, Satoru Hagiwara, and Masatoshi Kudo. 2023.
View at Publisher |
View at Google Scholar
- Lerner VT, Donnellan NM, Siedhoff MT, Truong MD, King CR. Care Delivery for Patients with Leiomyomas: Failures, Real-Life Experiences, Analysis of Barriers, and Proposed Restorative Remedies. Health Equity. 2023 Aug 25;7(1):439-452. doi: 10.1089/heq.2022.0116. PMID: 37638119; PMCID: PMC10457642.
View at Publisher |
View at Google Scholar
- Jiang, Y.; Qin, S.; Wang, Y.; Liu, Y.; Liu, N.; Tang, L.; Fang, J.; Jia, Q.; Huang, X. Intravoxel Incoherent Motion Diffusion-Weighted MRI for Predicting the Efficacy of High-Intensity Focused Ultrasound Ablation for Uterine Fibroids. Frontiers in Oncology 2023, 13. https://doi.org/10.3389/fonc.2023.1178649.
View at Publisher |
View at Google Scholar
- Labate, Angelo, Salvatore Bertino, Rosa Morabito, Chiara Smorto, Annalisa Militi, Simona Cammaroto, Carmelo Anfuso, Francesco Tomaiuolo, Paolo Tonin, Silvia Marino, and et al. 2023.
View at Publisher |
View at Google Scholar
- Shu C, Lim M, Fang A. Transarterial Embolization and Percutaneous Ablation of Primary and Metastatic Soft Tissue Tumors. Life (Basel). 2023 Jun 30;13(7):1485. doi: 10.3390/life13071485. PMID: 37511864; PMCID: PMC10381432.
View at Publisher |
View at Google Scholar
- Kweon S, Park J, Sim Y, Kwack JY, Kwon YS. Clinical Outcomes of Conservative Surgery for Diffuse Uterine Leiomyomatosis: Preliminary Experience of 17 Cases in a Single Center. J Clin Med. 2023 Dec 12;12(24):7638. doi: 10.3390/jcm12247638. PMID: 38137706; PMCID: PMC10743964.
View at Publisher |
View at Google Scholar
- Catena U, Mirandola M, Capomacchia FM, Fanfani F, Scambia G. A new surgical approach for fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma: a step-by-step technique. Facts Views Vis Obgyn. 2023 Mar;15(1):79-81. doi: 10.52054/FVVO.15.1.058. PMID: 37010338; PMCID: PMC10392118.
View at Publisher |
View at Google Scholar
- Yan, J., Wu, T., Zhang, J. et al. Revolutionizing the female reproductive system research using microfluidic chip platform. J Nanobiotechnol 21, 490 (2023). https://doi.org/10.1186/s12951-023-02258-7
View at Publisher |
View at Google Scholar
- Hong IS. Endometrial stem/progenitor cells: Properties, origins, and functions. Genes Dis. 2022 Aug 31;10(3):931-947. doi: 10.1016/j.gendis.2022.08.009. PMID: 37396532; PMCID: PMC10308170.
View at Publisher |
View at Google Scholar
- Heting M, Wenping L, Yanan W, Dongni Z, Xiaoqing W, Zhli Z. Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies. Heliyon. 2023 Mar 22;9(4):e14733. doi: 10.1016/j.heliyon.2023.e14733. PMID: 37089342; PMCID: PMC10119507.
View at Publisher |
View at Google Scholar
- Surrey ES. GnRH agonists in the treatment of symptomatic endometriosis: a review. F S Rep. 2022 Nov 21;4(2 Suppl):40-45. doi: 10.1016/j.xfre.2022.11.009. PMID: 37223763; PMCID: PMC10201290.
View at Publisher |
View at Google Scholar
- Gupta, Divya, Shubham Singh, Sangeeta Shukla, and Sadhana Shrivastava.
View at Publisher |
View at Google Scholar
- Es-Haghee Ashteany S, Vahid Dastjerdi M, Tabarrai M, Nejatbakhsh F, Sadati Lamardi SN, Rahmani A, Azizkhani M, Tavoli Z. Effectiveness of Persian Golnar on Excessive Menstrual Bleeding in Women with Abnormal Uterine Bleeding, Compared to Tranexamic Acid: A Triple-Blind, Randomized Equivalence Trial. Evid Based Complement Alternat Med. 2023 Jul 20;2023:5355993. doi: 10.1155/2023/5355993. PMID: 37520025; PMCID: PMC10374373.
View at Publisher |
View at Google Scholar
- Addissouky TA, Ali MMA, El Tantawy El Sayed I, Wang Y. Recent Advances in Diagnosing and Treating Helicobacter pylori through Botanical Extracts and Advanced Technologies. Arch Pharmacol Ther. 2023;5(1):53-66. https://doi.org/10.33696/Pharmacol.4.045
View at Publisher |
View at Google Scholar
- Puglia LT, Lowry J, Tamagno G. Vitex agnus castus effects on hyperprolactinaemia. Front Endocrinol (Lausanne). 2023 Nov 21;14:1269781. doi: 10.3389/fendo.2023.1269781. PMID: 38075075; PMCID: PMC10702745.
View at Publisher |
View at Google Scholar
- Addissouky TA, et al. efficiency of mixture of olive oil and figs as an antiviral agents: a review and perspective, International Journal of Medical Science and Health Research, ISSN:2581-3366, Volume 4, Issue 4, Aug 2020, page 107-111, http://ijmshr.com/link/208
View at Publisher |
View at Google Scholar
- Chen, Huize, Chujun Deng, Zeyu Meng, and Shengxi Meng.
View at Publisher |
View at Google Scholar
- Amzajerdi, A., Keshavarz, M., Ghorbali, E. et al. The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial. BMC Women's Health 23, 138 (2023). https://doi.org/10.1186/s12905-023-02284-5
View at Publisher |
View at Google Scholar
- T A Addissouky, A A Khalil, A E El Agroudy, Assessment of potential biomarkers for early detection and management of Glomerulonephritis patients with diabetic diseases, American Journal of Clinical Pathology, Volume 160, Issue Supplement_1, November 2023, Pages S18–S19, https://doi.org/10.1093/ajcp/aqad150.040
View at Publisher |
View at Google Scholar
- T A Addissouky, A A Khalil, A E El Agroudy, Assessing the Efficacy of a Modified Triple Drug Regimen Supplemented with Mastic Gum in the Eradication of Helicobacter pylori Infection, American Journal of Clinical Pathology, Volume 160, Issue Supplement_1, November 2023, Page S19, https://doi.org/10.1093/ajcp/aqad150.041
View at Publisher |
View at Google Scholar
- T A Addissouky, A A Khalil, Detecting Lung Cancer Stages Earlier By Appropriate Markers Rather Than Biopsy And Other Techniques, American Journal of Clinical Pathology, Volume 154, Issue Supplement_1, October 2020, Pages S146–S147, https://doi.org/10.1093/ajcp/aqaa161.320
View at Publisher |
View at Google Scholar
- Tamer Addissouky, Detecting Liver Fibrosis by Recent Reliable Biomarkers in Viral Hepatitis Patients, American Journal of Clinical Pathology, Volume 152, Issue Supplement_1, October 2019, Page S85, https://doi.org/10.1093/ajcp/aqz117.000
View at Publisher |
View at Google Scholar
- Addissouky, T.A., Sayed, I.E.T.E., Ali, M.M.A. et al. Latest advances in hepatocellular carcinoma management and prevention through advanced technologies. Egypt Liver Journal 14, 2 (2024). https://doi.org/10.1186/s43066-023-00306-3
View at Publisher |
View at Google Scholar
- Sahni, Maneesha, and Emily S. Day.
View at Publisher |
View at Google Scholar
- Yuxue J, Ran S, Minghui F, Minjia S. Applications of nanomaterials in endometriosis treatment. Front Bioeng Biotechnol. 2023 May 9;11:1184155. doi: 10.3389/fbioe.2023.1184155. PMID: 37229500; PMCID: PMC10203239.
View at Publisher |
View at Google Scholar
- Addissouky, T.A., Wang, Y., El Sayed, I.E. et al. Recent trends in Helicobacter pylori management: harnessing the power of AI and other advanced approaches. Beni-Suef Univ J Basic Appl Sci 12, 80 (2023). https://doi.org/10.1186/s43088-023-00417-1
View at Publisher |
View at Google Scholar
- Haque, Munima, Md Salman Shakil, and Kazi Mustafa Mahmud. 2023.
View at Publisher |
View at Google Scholar
- von Ende E, Ryan S, Crain MA, Makary MS. Artificial Intelligence, Augmented Reality, and Virtual Reality Advances and Applications in Interventional Radiology. Diagnostics (Basel). 2023 Feb 27;13(5):892. doi: 10.3390/diagnostics13050892. PMID: 36900036; PMCID: PMC10000832.
View at Publisher |
View at Google Scholar
- Chen M, Kong W, Li B, Tian Z, Yin C, Zhang M, Pan H, Bai W. Revolutionizing hysteroscopy outcomes: AI-powered uterine myoma diagnosis algorithm shortens operation time and reduces blood loss. Front Oncol. 2023 Dec 8;13:1325179. doi: 10.3389/fonc.2023.1325179. PMID: 38144535; PMCID: PMC10739391.
View at Publisher |
View at Google Scholar
- Addissouky TA, El Tantawy El Sayed I, Ali MMA, Wang Y, El Baz A, Khalil AA, et al. Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions J Cell Immunol. 2023;5(4):127-126. https://doi.org/10.33696/immunology.5.178
View at Publisher |
View at Google Scholar
- Zhao A, Du X, Yuan S, Shen W, Zhu X, Wang W. Automated Detection of Endometrial Polyps from Hysteroscopic Videos Using Deep Learning. Diagnostics (Basel). 2023 Apr 13;13(8):1409. doi: 10.3390/diagnostics13081409. PMID: 37189510; PMCID: PMC10137953.
View at Publisher |
View at Google Scholar
- E, K., S, P., R, G. et al. Advantages and pitfalls in utilizing artificial intelligence for crafting medical examinations: a medical education pilot study with GPT-4. BMC Med Educ 23, 772 (2023). https://doi.org/10.1186/s12909-023-04752-w
View at Publisher |
View at Google Scholar
- Giudice LC, Oskotsky TT, Falako S, Opoku-Anane J, Sirota M. Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations. FASEB J. 2023 Sep;37(9):e23130. doi: 10.1096/fj.202300907. PMID: 37641572; PMCID: PMC10503213.
View at Publisher |
View at Google Scholar
- Yang J, Barkley JE, Bhattarai B, Firouzi K, Monk BJ, Coonrod DV, Zenhausern F. Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid. Int J Mol Sci. 2023 May 12;24(10):8683. doi: 10.3390/ijms24108683. PMID: 37240034; PMCID: PMC10218319.
View at Publisher |
View at Google Scholar
- Addissouky TA, Ali MMA, El Tantawy El Sayed I, Wang Y, El Baz A, Elarabany N, et al. Preclinical Promise and Clinical Challenges for Innovative Therapies Targeting Liver Fibrogenesis. Arch Gastroenterol Res. 2023;4(1):14-23. https://doi.org/10.33696/Gastroenterology.4.044
View at Publisher |
View at Google Scholar
- Liu, Yujiang, Wanwan Wen, Linxue Qian, and Ruifang Xu.
View at Publisher |
View at Google Scholar
- Siminiuc R, Ţurcanu D. Impact of nutritional diet therapy on premenstrual syndrome. Front Nutr. 2023 Feb 1;10:1079417. doi: 10.3389/fnut.2023.1079417. PMID: 36819682; PMCID: PMC9928757.
View at Publisher |
View at Google Scholar
- Addissouky T, Ali M, El Tantawy El Sayed I, Wang Y. Revolutionary Innovations in Diabetes Research: From Biomarkers to Genomic Medicine. IJDO 2023; 15 (4) :228-242 https://doi.org/10.18502/ijdo.v15i4.14556
View at Publisher |
View at Google Scholar
- Vafaei, Somayeh, Michał Ciebiera, Mervat M. Omran, Mohammad Mousaei Ghasroldasht, Qiwei Yang, Tanya Leake, Rochelle Wolfe, Mohamed Ali, and Ayman Al-Hendy. 2023.
View at Publisher |
View at Google Scholar
- Patel N, Chaudhari K, Patel D, Joshi J. High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Review. Cureus. 2023 Sep 4;15(9):e44680. doi: 10.7759/cureus.44680. PMID: 37809132; PMCID: PMC10550780.
View at Publisher |
View at Google Scholar
- Candiani M, Ottolina J, Salmeri N, D'Alessandro S, Tandoi I, Bartiromo L, Schimberni M, Ferrari S, Villanacci R. Minimally invasive surgery for ovarian endometriosis as a mean of improving fertility: Cystectomy vs. CO2 fiber laser ablation what do we know so far? Front Surg. 2023 Mar 27;10:1147877. doi: 10.3389/fsurg.2023.1147877. PMID: 37051570; PMCID: PMC10083313.
View at Publisher |
View at Google Scholar
- Whitaker LHR, Middleton LJ, Daniels JP, et al. Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial. EClinicalMedicine. 2023 May 18;60:101995. doi: 10.1016/j.eclinm.2023.101995. PMID: 37251622; PMCID: PMC10209678.
View at Publisher |
View at Google Scholar
- MacGregor, Becky, Malcolm G. Munro, and Mary A. Lumsden.
View at Publisher |
View at Google Scholar
- Swingle, K.L., Ricciardi, A.S., Peranteau, W.H. et al. Delivery technologies for women’s health applications. Nat Rev Bioeng 1, 408–425 (2023). https://doi.org/10.1038/s44222-023-00040-w
View at Publisher |
View at Google Scholar
- Chehelgerdi, M., Chehelgerdi, M., Allela, O.Q.B. et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer 22, 169 (2023). https://doi.org/10.1186/s12943-023-01865-0
View at Publisher |
View at Google Scholar